Drugs
-
Naproxen Information
FDA Alert: Based on emerging information from a long-term prevention trial, the risk of cardiovascular and cerebrovascular events may increase among patients taking naproxen. FDA will be analyzing all available information from these studies to determine whether additional regulatory action is needed.
1/10/2005
-
Related Information
Naproxen Healthcare Professional Sheet 2009 (PDF - 19KB)Prescribing Information and Medication Guide [for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)] Jul 2008 Decision Memo - Analysis and Recommendations for Agency Action - COX-2 Selective and Non-selective NSAIDs (PDF - 143KB)
Issued 4/6/2005Public Health Advisory: Non-Steroidal Anti-Inflammatory Drug Products (NSAIDS)
12/23/2004Naproxen Historical Patient Information Sheet from 2004 (PDF - 34KB)
(includes FDA Alert from 12/23/2004)Naproxen Information - Healthcare Professional Sheet pdf (PDF - 36KB)
(includes FDA Alert from 12/23/2004)
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-
